DYNLT1 — Dynein Light Chain Tctex-Type 1

Migration, Crosslink

📖

DYNLT1 — Dynein Light Chain Tctex-Type 1

active

wiki page Created: 2026-04-02T07:19:17 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-dynlt1

📖 Wiki Page

gene2182 wordssynced 2026-04-02

DYNLT1 — Dynein Light Chain Tctex-Type 1

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DYNLT1 — Dynein Light Chain Tctex-Type 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>DYNLT1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dynein Cytoplasmic Light Chain Tctex-Type 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q21</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6993</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>162376</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000126653</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P63172</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>110 amino acids (homo-dimer)</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

...

DYNLT1 — Dynein Light Chain Tctex-Type 1

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DYNLT1 — Dynein Light Chain Tctex-Type 1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>DYNLT1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dynein Cytoplasmic Light Chain Tctex-Type 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6q21</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6993</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>162376</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000126653</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P63172</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>110 amino acids (homo-dimer)</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The DYNLT1 gene (Dynein Cytoplasmic Light Chain Tctex-Type 1) encodes the Tctex-1 subunit of the cytoplasmic dynein complex, a minus-end-directed microtubule motor protein essential for retrograde axonal transport in neurons. Cytoplasmic dynein is responsible for transporting cargo from nerve terminals toward the cell body along microtubule tracks, moving vesicles, organelles, signaling complexes, and protein aggregates toward the soma for degradation[@schiavo2020] or recycling. DYNLT1 is one of several dynein light chains that confer cargo specificity to the dynein complex, allowing it to recognize and transport diverse cellular cargoes. Located on chromosome 6q21, DYNLT1 is expressed predominantly in the nervous system, particularly in the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, retina, and peripheral nervous system. The protein has been implicated in multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis, where axonal transport defects are increasingly recognized as early and critical pathogenic events. The Tctex-1 subunit itself interacts with specific cargo adaptors and has been shown to directly interact with pathogenic proteins like mutant huntingtin, making it a particularly interesting target for understanding neurodegeneration mechanisms.

Gene Information

The Cytoplasmic Dynein Complex

Cytoplasmic dynein is a large multi-subunit motor protein complex essential for retrograde transport in all eukaryotic cells. The dynein complex consists of:

Core Motor Subunits

Dynein Heavy Chain (DYNC1H1): Contains the ATPase motor domain and microtubule-binding domain, providing the force-generating capability. The heavy chain is approximately 500 kDa and forms a dimer that walks along microtubules toward the minus end.
Dynein Intermediate Chain (DYNC1I1/DYNC1I2): Forms a dimer that serves as the primary cargo-binding platform, connecting the heavy chains to the light chain subunits.
Dynein Light Intermediate Chain (DYNC1LI1/DYNC1LI2): Additional cargo-binding subunits that modulate dynein function.

Light Chain Subunits

The dynein light chain family includes multiple isoforms:

DYNLT1 (Tctex-1): The Tctex-type light chain
DYNLT2: Another Tctex family member
DYNLRB1/DYNLRB2 (Roadblock): The roadblock-type light chains
DYNLL1/DYNLL2 (LC8): The LC8-type light chains

Each light chain has distinct cargo-binding properties. Tctex-1 (DYNLT1) has been shown to interact with specific cargo adaptors and pathogenic proteins, making it particularly relevant to neurodegenerative disease research.

Molecular Function and Mechanism

DYNLT1 functions as part of the dynein light chain complex, contributing to cargo specificity and regulation of the dynein motor:

Cargo Recognition

DYNLT1 contains a conserved dynein light chain domain that forms a dimer and interfaces with cargo adaptor proteins. These adaptors recognize specific cargoes (vesicles, organelles, signaling complexes) and link them to the dynein complex. DYNLT1 has been shown to directly bind to:

Huntingtin: Mutant huntingtin protein associated with Huntington's disease
Rab proteins: Small GTPases that regulate vesicle trafficking
Various cargo adaptor complexes: Including those involved in transport of neurotrophin receptors and synaptic components

Transport Mechanism

Dynein moves along microtubules through a coordinated ATP hydrolysis cycle. The motor domain at the C-terminus of the heavy chain binds to microtubules and undergoes conformational changes that produce movement toward the minus end (the cell body in neurons). The light chains at the N-terminus serve to regulate motor activity and attach cargo. Microtubules in axons are polarized, with plus ends pointing toward synapses and minus ends toward the cell body. This orientation means that dynein-mediated transport moves cargo from the synapse back toward the soma.

Regulation

DYNLT1 function is regulated through:

Phosphorylation: Both DYNLT1 and its cargo adaptors can be phosphorylated, affecting binding affinity
Dynein complex assembly: The light chains must correctly assemble with the rest of the dynein complex for function
Post-translational modifications: Acetylation and other modifications of microtubules affect dynein processivity

Axonal Transport in Neurons

Neurons have extremely long axons that can extend over a meter in human motor neurons. This architecture creates unique challenges for cellular logistics, requiring sophisticated transport systems to move materials between the cell body and distant nerve terminals:

Retrograde Transport (Dynein)

The dynein complex powers retrograde transport, moving cargo from the synapse toward the cell body. This direction is essential for:

Synaptic maintenance: Delivering proteins and lipids synthesized in the soma to synaptic terminals
Neurotrophin signaling: Transporting internalized neurotrophin receptors back to the soma for signaling
Aggregate clearance: Moving protein aggregates and damaged organelles toward the soma for degradation
Infection defense: Transporting pathogens and damaged components for immune surveillance

Anterograde Transport (Kinesin)

Kinesin motors (primarily kinesin-1) mediate anterograde transport, moving cargo from the cell body toward the synapse. The coordinated activity of kinesin and dynein ensures bidirectional transport throughout the neuron.

Transport Defects in Neurodegeneration

Axonal transport defects are among the earliest pathologies in many neurodegenerative diseases:

Reduced transport velocity
Accumulation of cargo at axonal swellings
Disruption of microtubule integrity
Impaired organelle trafficking
Failure to clear protein aggregates

These defects likely precede and contribute to neuronal death, making understanding dynein function critical for developing disease-modifying therapies.

Expression and Localization

DYNLT1 is expressed throughout the nervous system:

Brain Regions

Cerebral Cortex: Particularly layer V pyramidal neurons
Hippocampus: CA1-CA3 regions and dentate gyrus
Basal Ganglia: Striatum and substantia nigra pars compacta
Cerebellum: Purkinje cells and granule cells
Brainstem: Various motor and sensory nuclei
Retina: Photoreceptor cells and ganglion cells

Cell Type Expression

DYNLT1 is expressed in all neuronal subtypes, including:

Projection neurons
Interneurons
Motor neurons
Sensory neurons
Retina cells

Within neurons, DYNLT1 localizes to:

Axon shafts (along microtubules)
Synaptic terminals
Axonal branching points
Growth cones during development

The widespread expression reflects the fundamental importance of dynein-mediated transport in all neuronal subtypes.

DYNLT1 in Neurodegenerative Diseases

Huntington's Disease

DYNLT1 has a particularly significant role in Huntington's disease, where it directly interacts with mutant huntingtin protein:

Direct binding: Mutant huntingtin (with expanded polyglutamine tracts) directly binds to DYNLT1
Transport impairment: This binding hijacks the dynein complex, impairing normal retrograde transport
Aggregate trafficking: Huntingtin aggregates are transported by dynein, but mutant huntingtin disrupts this process
Neuronal vulnerability: Cortical and striatal neurons show particular vulnerability to transport defects

In HD models, dynein-mediated transport of brain-derived neurotrophic factor (BDNF) is impaired, contributing to the characteristic degeneration of striatal neurons. DYNLT1 dysfunction may also affect the transport of other cargoes essential for neuronal survival.

Alzheimer's Disease

In Alzheimer's disease, DYNLT1 and dynein function are affected at multiple levels:

Amyloid-beta effects: Aβ oligomers can impair dynein function and reduce transport
Tau pathology: Hyperphosphorylated tau disrupts microtubule integrity, indirectly affecting dynein-mediated transport
Nerve growth factor (NGF) signaling: Impaired retrograde transport of NGF TrkA receptors affects survival signaling
Endolysosomal trafficking: Dynein-dependent transport of endosomes is disrupted in AD

Dynein dysfunction contributes to the characteristic accumulation of organelles and aggregates in AD-affected neurons.

Parkinson's Disease

In Parkinson's disease, dynein-mediated transport is relevant through several mechanisms:

Alpha-synuclein pathology: α-Synuclein aggregates may interfere with dynein function
Mitochondrial transport: Impaired transport of mitochondria contributes to energy deficits
Lysosomal trafficking: Autophagosome-lysosome fusion requires dynein for movement to the soma
Dopaminergic neuron vulnerability: The unique architecture of dopaminergic neurons may make them particularly susceptible to transport defects

Mutations in dynein genes (DYNC1H1) have been associated with Charcot-Marie-Tooth disease, a peripheral neuropathy, suggesting that dynein dysfunction can cause neurodegeneration.

Amyotrophic Lateral Sclerosis (ALS)

In ALS, axonal transport defects are early and prominent features:

TDP-43 pathology: TDP-43 aggregates disrupt transport machinery
RNA transport: Impaired transport of RNA granules containing TDP-43
Synaptic dysfunction: Reduced delivery of synaptic proteins to neuromuscular junctions
Axonal degeneration: Transport failure precedes axonal degeneration

Dynein dysfunction may contribute to the characteristic dying-back pattern of axonal degeneration in ALS.

Other Neurodegenerative Conditions

DYNLT1 may also play roles in:

Retinitis pigmentosa: DYNLT1 mutations affect photoreceptor function
Charcot-Marie-Tooth disease: DYNC1H1 mutations cause peripheral neuropathy
Spinal muscular atrophy: Transport defects contribute to motor neuron degeneration

Therapeutic Implications

Understanding DYNLT1 function in neurodegeneration suggests several therapeutic strategies:

Small Molecule Approaches

Dynein activators: Compounds that enhance dynein function and transport
Microtubule stabilizers: Drugs that stabilize microtubules to improve transport
Cargo-specific modulators: Molecules that enhance transport of specific cargoes

Gene Therapy Strategies

DYNLT1 overexpression: Increase dynein light chain levels to enhance transport
Cargo adaptor modification: Engineer improved adaptor proteins
Microtubule-based therapies: Target microtubule integrity

Protein Aggregation Approaches

Aggregate clearance enhancers: Promote clearance of transported aggregates
Dynein-aggregate dissociation: Prevent pathogenic proteins from hijacking dynein

Combination Approaches

Neurotrophin delivery: Enhance survival signaling independent of transport
Gene therapy combinations: Multiple targets addressing different aspects of pathogenesis

Interactions and Pathways

DYNLT1 interacts with several key cellular pathways:

Direct Protein Interactions

Huntingtin (HTT): Direct binding, particularly mutant huntingtin
Dynein heavy chain: Assembly into the dynein complex
Dynein intermediate chain: Structural interaction
Cargo adaptors: Various adaptors that link cargo to dynein

Signaling Pathways

Neurotrophin signaling: NGF, BDNF retrograde signaling
Autophagy: Transport of autophagosomes toward lysosomes
Endocytosis: Retrograde trafficking of endosomes
Synaptic vesicle recycling: Transport of synaptic components

Amyloid precursor protein (APP): Potential interaction in AD
Alpha-synuclein: Potential dysfunction in PD
TDP-43: Potential interaction in ALS

Regulation of DYNLT1

DYNLT1 expression and function are regulated at multiple levels:

Transcriptional Regulation

Neuronal activity: Activity-dependent regulation of expression
Developmental timing: Different expression patterns during development
Cell type specificity: Variable expression across neuronal subtypes

Post-translational Regulation

Phosphorylation: Multiple serine/threonine sites can be phosphorylated
Protein interactions: Assembly into dynein complex affects function
Subcellular localization: Targeting to specific neuronal compartments

Animal Models

Several model systems have been used to study DYNLT1 function:

Drosophila Models

Dynein light chain mutants: Show neurodegeneration and transport defects
Huntingtin interaction models: Demonstrate how mutant huntingtin affects transport
Retinal degeneration models: DYNLT1 dysfunction causes photoreceptor loss

Mouse Models

Dynein mutants: Show motor and sensory deficits
Transgenic models: Overexpression or knockout studies
Disease models: HD, AD, and PD models showing dynein involvement

Cell Culture Models

Neuronal cultures: Primary neurons for transport studies
Organotypic cultures: Brain slice cultures for mechanistic studies

Research Directions

Current research areas include:

Structural studies: Understanding DYNLT1 structure and cargo recognition

Cargo specificity: Defining which cargoes specifically require DYNLT1

Disease mechanisms: Elucidating how DYNLT1 contributes to specific diseases

Therapeutic targeting: Developing drugs that modulate DYNLT1 function

Biomarkers: Identifying markers of transport dysfunction

Gene therapy: Viral vector approaches to enhance dynein function

Axon guidance: Understanding how transport affects axon pathfinding

Conclusion

The DYNLT1 gene encodes the Tctex-1 subunit of cytoplasmic dynein, a critical component of the neuronal transport machinery responsible for retrograde axonal transport. By mediating the movement of cargo from synapses back to the cell body, DYNLT1 enables essential functions including neurotrophin signaling, synaptic maintenance, organelle quality control, and clearance of protein aggregates. In neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS, dynein-mediated transport is impaired, contributing to early pathogenesis and subsequent neuronal death. The direct interaction of DYNLT1 with pathogenic proteins like mutant huntingtin highlights its particular relevance to disease mechanisms. Therapeutic strategies targeting DYNLT1 and dynein function represent promising approaches for developing disease-modifying treatments for these devastating conditions.

References

[Vallee RB, et al. Cytoplasmic dynein in neuronal transport (2001)](https://pubmed.ncbi.nlm.nih.gov/11580929/)

[Caviston JP, et al. Huntington and dynein interactions in intracellular transport (2007)](https://pubmed.ncbi.nlm.nih.gov/17215591/)

[Endo K, et al. Dynein dysfunction in neurodegenerative disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25740613/)

[Suijo Y, et al. Dynein dysfunction in retinal degeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32866615/)

[Schiavo G, et al. Retrograde transport in axonal degeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32845840/)

[Saxton WM, et al. Drosophila cytoplasmic dynein mutants (1986)](https://pubmed.ncbi.nlm.nih.gov/3528184/)

[Kural C, et al. Kinesin and dynein in vesicle transport (2005)](https://pubmed.ncbi.nlm.nih.gov/15891786/)

[Morfini DA, et al. Axonal transport defects in neurodegeneration (2009)](https://pubmed.ncbi.nlm.nih.gov/19137721/)

[Gunawardena S, et al. Disruption of axonal transport by polyglutamine diseases (2003)](https://pubmed.ncbi.nlm.nih.gov/12890801/)

[Strickland SL, et al. Dynein mutations and axonal transport defects (2014)](https://pubmed.ncbi.nlm.nih.gov/25135137/)

[Lorenzo DN, et al. The Tctex-1 subunit of dynein in disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20585536/)

[Moughamian AJ, et al. Polarized trafficking in neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23401004/)

[Roberts AJ, et al. Motor proteins and organelle transport (2016)](https://pubmed.ncbi.nlm.nih.gov/27241914/)

[Cooper SE, et al. Dynein and neurodegeneration in Drosophila (2019)](https://pubmed.ncbi.nlm.nih.gov/31209134/)

[Baas PW, et al. The neuronal cytoskeleton (1999)](https://pubmed.ncbi.nlm.nih.gov/10627140/)

📖 View canonical wiki page →

Related Entities

DYNLT1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-dynlt1
kg_node_id	DYNLT1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-f42535408929
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-dynlt1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

20%

Debates

0

Incoming

4

Outgoing

8

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

DYNLT1 — Dynein Light Chain Tctex-Type 1

DYNLT1 — Dynein Light Chain Tctex-Type 1

Overview

DYNLT1 — Dynein Light Chain Tctex-Type 1

Overview

Gene Information

The Cytoplasmic Dynein Complex

Core Motor Subunits

Light Chain Subunits

Molecular Function and Mechanism

Cargo Recognition

Transport Mechanism

Regulation

Axonal Transport in Neurons

Retrograde Transport (Dynein)

Anterograde Transport (Kinesin)

Transport Defects in Neurodegeneration

Expression and Localization

Brain Regions

Cell Type Expression

DYNLT1 in Neurodegenerative Diseases

Huntington's Disease

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Other Neurodegenerative Conditions

Therapeutic Implications

Small Molecule Approaches

Gene Therapy Strategies

Protein Aggregation Approaches

Combination Approaches

Interactions and Pathways

Direct Protein Interactions

Signaling Pathways

Disease-Related Interactions

Regulation of DYNLT1

Transcriptional Regulation

Post-translational Regulation

Animal Models

Drosophila Models

Mouse Models

Cell Culture Models

Research Directions

Conclusion

See Also

References

💬 Discussion